Japan Pharmaceutical Market Outlook
Deregulation and More Efficient New Drug Approval Process Attract Foreign
Investment and Improve the Competitiveness of Japanese Players
Summary
GBI Research, the leading business
intelligence provider, has released its latest research “Japan Pharmaceutical
Market Outlook Deregulation and More Efficient New Drug Approval Process
Attract Foreign Investment and Improve the Competitiveness of Japanese
Players”. Japan’s pharmaceutical industry is the second largest in the world,
worth $89 billion in 2011 or 10% of the world market. The industry grew from
$62.8 billion in 2005 to its current value at a Compound Annual Growth Rate
(CAGR) of 5.1%.
Growth of the domestic
pharmaceutical industry has recently been hampered by biennial drug price
reductions, which are expected to continue as the government attempts to cut
healthcare expenditure. Price reviews are also constrained by a national health
budget, which limits the increase of drug prices. In addition, the gradual increase
in market share and competition from generics has depressed market value and
will continue to do so as government policy promotes their use.
To
Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/167326
Scope
- The report assesses characteristics of the Japanese pharmaceutical market, detailing recent regulatory changes, supply chain and competitive landscape. It also draws on macroeconomic and demographic factors and the implications on healthcare policy.
- A macroeconomic analysis of Japan, focusing on key economic parameters such as Gross Domestic Product (GDP), inflation and unemployment. The implications of the global financial crisis in 2008 and natural disaster in 2011 are considered.
- The changing demographic landscape and implications on health economics and policy-making.
- The industry characteristics section presents an overview of pricing policies, the regulatory landscape, new drug approval process and pharmaceutical supply chain in Japan. Notable changes that have occurred over recent years, in an attempt to improve the regulatory system and reduce drug review times, are highlighted.
- The report then analyzes the competitive landscape in Japan, including the major domestic companies and M&A. The discussed regulatory reforms and cooperation between government and industry have improved the international competitiveness of Japan’s pharmaceutical market. Coupled with a number of mergers, the industry now consists of well-known multinationals. The competitive landscape section confirms the top five Japanese pharmaceutical companies by revenue, according to GBI Research data.
- The report concludes by providing an overview of the drivers and barriers currently facing the Japanese pharmaceutical industry.
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis-details/japan-pharmaceutical-market-outlook-deregulation-and-more-efficient-new-drug-approval-process-attract-foreign-investment-and-improve-the-competitiveness-of-japanese-players
Reasons to buy
- Primarily, the report will allow clients to gain a strong understanding of the economic and healthcare challenges facing Japan.
- In addition, the report will assist in identifying opportunities within Japan’s pharmaceutical market, including:
- Potential for market growth A number of factors could provide strong potential for sales growth in the Japanese pharmaceutical market. Examples include the world leading life expectancy and associated increase in lifestyle diseases, and government initiatives to prevent such diseases, which provides opportunities for healthcare and pharmaceutical companies, who often carry out the work.
- The report provides a source of information covering Japan’s regulatory landscape, and importantly, recent deregulation, to help identify the reasons Japan has become an attractive market for big pharma.
- The report will provide new market entrants with a comprehensive overview of the leading Japanese pharmaceutical companies, and the specific therapeutic indications they are currently targeting.
- Overall, allowing clients to determine whether the Japanese pharmaceutical market will provide them with commercially viable opportunities for growth.
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/
